<DOC>
	<DOCNO>NCT02285673</DOCNO>
	<brief_summary>Duchenne muscular dystrophy ( DMD ) genetic disorder cause absence dystrophin characterize progressive muscle degeneration . There cure DMD present , several strategy under-researched treatment DMD steroid treatment , gene theraphy , exon skipping , stop codon read gene repair , cell theraphy theraphy drug help produce utrophin protein . The aim study investigate eficacy human umblical cord mesenchymal stem cell DMD understand wild type gene transfer patient .</brief_summary>
	<brief_title>Efficacy Umbilical Cord Mesenchymal Stem Cells Duchenne Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>Patients diagnosis DMD proven clinically genetically Age 720 Patients need partial respiratory support , day Patients le equal stage I NIH , Liver , renal cardiac function Patients without cancer Patients without allergic disease Patients without bleed diathesis , Patients need complete respiratory support Patients stage II NIH , Liver , renal cardiac function Patients bleed diathesis allergic disease</criteria>
	<gender>Male</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>umbilical cord , mesenchymal stem cell</keyword>
</DOC>